Australia markets closed

Entheon Biomedical Corp. (ENTBF)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.07600.0000 (0.00%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/11/2023
30/11/2022
30/11/2021
30/11/2020
31/03/2020
Total revenue
370.323
-
189.677
0
0
0
Cost of revenue
-
-
-
12.54
0
-
Gross profit
-
-
-
9.13
0
-
Operating expenses
Research development
2.39
-
1,199
1,212
442.56
-
Selling general and administrative
838.277
-
2,589
6,998
3,931
144.514
Total operating expenses
841.591
-
3,790
8,215
4,377
144.514
Operating income or loss
-471.268
-
-3,600
-8,215
-4,377
-144.514
Interest expense
0
-
-
-
-
0
Total other income/expenses net
0.176
-
1,538
205.452
-12.275
-22.271
Income before tax
-470.336
-
-2,061
-7,999
-4,381
-146.783
Income tax expense
0
-
-
-
-
0
Income from continuing operations
-470.336
-
-2,061
-7,999
-4,381
-146.783
Net income
-6,068
-
-8,521
-8,887
-4,381
-146.783
Net income available to common shareholders
-6,068
-
-8,521
-8,887
-4,381
-146.783
Basic EPS
-1.14
-0.05
-1.44
-1.60
-1.60
-
Diluted EPS
-1.14
-0.05
-1.44
-1.60
-1.60
-
Basic average shares
5,909
5,909
5,909
5,429
2,744
-
Diluted average shares
5,909
5,909
5,909
5,429
2,744
-